JEMGX
Price
$9.19
Change
-$0.18 (-1.92%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

JEMGX vs RNWFX

Header iconJEMGX vs RNWFX Comparison
Open Charts JEMGX vs RNWFXBanner chart's image
JHancock Emerging Markets Equity R6
Price$9.19
Change-$0.18 (-1.92%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JEMGX vs RNWFX Comparison Chart
Loading...
VS
JEMGX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEMGX is a Buy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. JEMGX (1.42B). JEMGX pays higher dividends than RNWFX: JEMGX (1.63) vs RNWFX (1.51). JEMGX was incepted earlier than RNWFX: JEMGX (9 years) vs RNWFX (22 years). JEMGX is a more actively managed with annual turnover of: 37.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than JEMGX: RNWFX (250) vs JEMGX (1000000). RNWFX annual gain was more profitable for investors over the last year : 11.53 vs. JEMGX (7.68). RNWFX return over 5 years is better than : 22.38 vs. JEMGX (-6.95).
JEMGXRNWFXJEMGX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years22 years-
Gain YTD3.7657.24552%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.42B60.1B2%
Annual Yield % from dividends1.631.51108%
Returns for 1 year7.6811.5367%
Returns for 3 years-36.83-15.44238%
Returns for 5 years-6.9522.38-31%
Returns for 10 yearsN/A35.71-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio